Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 4: considerations in selection and use of disinfectants and antiseptics.
United States Pharmacopeia Chapter 797 Pharmaceutical Compounding-Sterile Preparations pertains to all preadministration manipulations and procedures involved in preparation of sterile compounds for application, implantation, infusion, inhalation, injection, insertion, instillation, or irrigation, including preparation, storage, and transportation. The chapter does not pertain to actual clinical administration of compounded sterile preparations to patients. The intent of Chapter 797 is simply to prevent patient harm and fatalities that may result from nonsterility, excessive endotoxin load, large content errors in stength of correct ingredients, or the presence of incorrect ingredients. Because the achievement of sterility requires that facilities meet minimum cleanliness standards, that personnel be trained adequately and undergo periodic testing and training in sterilization techniques, and that appropriate principles and pracitices be applied to sustain solution stability, compliance with Chapter 797 should be the goal of any facility where sterile preparations are compounded. Many pharmacies have already achieved compliance with Chapter 797, and those that have already met the new standards seem to support them strongly. This particular article discusses the standards set forth in United States Pharmacopeia Chapter 1072, which is referenced in Chapter 797, for the selection and use of disinfectants and antiseptics in the compounding pharmacy.